What the industry experts are saying about Pharma Marketing ROI
09 February 2006, NetworkPharma Ltd, Oxford, UK have published the first in their KeywordPharma series of brand new conference reports intended for individuals working in and around the global pharmaceutical industry.
Marketing ROI for Pharma: in-depth report from the eyeforpharma 5th Annual Pharmaceutical Marketing Congress Amsterdam, 14-15 November 2005 is now available for purchase.
The author, Dr Michel RM Rod, said: "The 5th Annual Pharmaceutical Marketing Congress - Marketing ROI for Pharma - held in Amsterdam 14-15 November 2005, organised by eyeforpharma, proved to be another successful event for those pharmaceutical managers/executives, consultants, healthcare practitioners and academics in attendance. Over the course of an excellent series of presentations, workshops and discussion panels, it became evident that although marketing return on investment (ROI) is still a very hot topic, it remains an area in which there is still much to learn and to apply."
Peter Llewellyn, Managing Director of NetworkPharma Ltd commented, "Priced at just GBP 40.00 (approx USD 72.00, Euros 60.00) the KeywordPharma Conference Insights provide a unique overview of expert opinion at a price that most individuals can afford. Until now much of this information has remained too costly to access easily for many individuals working within our industry."
All KeywordPharma publications can be purchased from ThePharmYard at www.ThePharmYard.com
NOTES
About the author
Dr Michel Rod left his role as Manager of Intellectual Property Development at the University of Calgary, Canada, to begin an academic career at the School of Marketing & International Business at the Victoria University of Wellington, New Zealand, in 2001. He has a medical sciences background having received a BSc (Hons) in Pharmacology & Toxicology from the University of Western Ontario and an MSc in Medical Sciences (Neurosciences) from the University of Calgary. After having worked for several years in medical research, and sales and marketing environments, he completed his PhD in Commerce at the University of Birmingham, UK, in 2003.
His research interests include the development and management of collaborative relationships amongst university, industry and government organisations within the health sciences sector, pharmaceutical promotions, as well as the commercialisation of university-developed intellectual property. He has published in Science and Public Policy, Qualitative Market Research, Canadian Journal of Neurosciences, Canadian Journal of Psychology, Stroke, Brain Research Bulletin, Management Research News, and the Journal of Transnational Management Development.
Written by pharmaceutical industry specialists, KeywordPharma publications are designed to be authoritative, relevant, succinct and helpful to pharmaceutical industry executives in their day-to-day work and in their longer term career development. Available to purchase individually as e-documents, they build into a specialist knowledge library for everyone working in and around the global pharmaceutical industry.
Developed and managed by NetworkPharma Ltd, ThePharmYard provides instant access to a unique database of specialist information which is particularly relevant to individuals working within the medical and pharmaceutical industries around the world. Titles from a diverse range of independent publishers are available to purchase in electronic document format for immediate access.
NetworkPharma Ltd is an independent, specialist company founded by Peter Llewellyn, to focus on novel approaches to disseminating information within the global medical and pharmaceutical industries. Peter Llewellyn previously founded and built the leading industry portal site, InPharm, which was subsequently purchased by John Wiley & Sons to manage alongside their other industry services, PharmaFile and Pharmafocus.
For more information contact:
For more information please contact us via our web site or directly contact Peter Llewellyn, Managing Director, NetworkPharma Ltd, email: peter@networkpharma.com, tel: +44 (0) 1865 865943
